Table 2.
6-MP |
MTX |
|||||
---|---|---|---|---|---|---|
Median | IQR | Range | Median | IQR | Range | |
Maintenance phase length (days) | 398 | 211-604 | 60-2546 | 393 | 202-602 | 60-2532 |
Total days supplied during maintenance | 300 | 162-498 | 3-25 | 284 | 148-472 | 2-86 |
Possession ratio, % | 85 | 71-97 | 5-205 | 81 | 67-93 | 2-309 |
Q1 | 55 | 43-63 | 5-69 | 54 | 43-60 | 2-65 |
Q2 | 77 | 73-81 | 70-84 | 75 | 70-77 | 66-80 |
Q3 | 90 | 97-93 | 85-96 | 86 | 83-89 | 81-92 |
Q4 | 103 | 99-108 | 97-205 | 100 | 97-105 | 93-309 |
Abbreviations: 6-MP, 6-mercaptopurine; MTX, methotrexate; IQR, interquartile range.